This result probably occurred because (i) the severity of the disease is the primary determinant of prognosis in critically ill lung cancer patients, not cancer itself; and (ii) of these 12 patients accepting rescue targeted therapy, five without oncogenic mutation and one unknown mutation patient received EGFR‐TKIs. This evidence concerns the gene EGFR and cancer.